510(k) Report

510(k) · Cleared

Cleared

Hemosil Factor Viii Deficient Plasma

K110237510(k) TraditionalCleared Jul 8, 2011163-day reviewClass II21 CFR 864.7290

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory CO · GJT Plasma, Coagulation Factor Deficient

Cleared on Jul 8, 2011 as substantially equivalent to K034007 (Instrumentation Laboratory CO, 2004) after a 163-day review. Its family tree reaches back 2 generations to 1989. 1 later device descends from it.

Decided
Jul 8, 2011
Review
163 days
Class
Class II
Product code
GJT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K893525 (1989). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2023: 1 descendant clearedK893525 · Factor Viii Deficient Plasma · Medical Diagnostic Technologies, Inc. · 1989K034007 · Hemosil Factor Viii Deficient Plasma · Instrumentation Laboratory CO · 20041990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 1 descendant K034007 · Hemosil Factor Viii Deficient Plasma · Instrumentation Laboratory CO · 2004K893525 · Factor Viii Deficient Plasma · Medical Diagnostic Technologies, Inc. · 19890
  1. Root · 2 generations backK893525 Factor Viii Deficient PlasmaMedical Diagnostic Technologies, Inc. · 1989
  2. 1 generation backK034007 Hemosil Factor Viii Deficient PlasmaInstrumentation Laboratory CO · 2004
  3. This deviceK110237 Hemosil Factor Viii Deficient PlasmaInstrumentation Laboratory CO · 2011
  4. Descendant · cites it directly · 0 of its ownK222831 CRYOcheck Factor VIII Deficient Plasma with VWFPrecision Biologic, Inc. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K222831CRYOcheck Factor VIII Deficient Plasma with VWFPrecision Biologic, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K893525Factor Viii Deficient PlasmaMedical Diagnostic Technologies, Inc.1989—
−1K034007Hemosil Factor Viii Deficient PlasmaInstrumentation Laboratory CO2004—
0 (this device)K110237Hemosil Factor Viii Deficient PlasmaInstrumentation Laboratory CO2011—
+1K222831CRYOcheck Factor VIII Deficient Plasma with VWFPrecision Biologic, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K110237, 1989–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GJT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GJT device

  1. #1 K222831 CRYOcheck Factor VIII Deficient Plasma with VWFscore 6.6 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K034007Hemosil Factor Viii Deficient Plasma
Summary page 1
…Substantial Equivalence Information: 1. Predicate device name(s): HemoslL Factor Vill deficient plasma (same name) 2. Predicate 510(k) number(s): K(034007 3. Comparison with predicate: Similarities The applicant, Hemosili Factor VilI deficie…
Instrumentation Laboratory CO2004—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K222831CRYOcheck Factor VIII Deficient Plasma with VWFPrecision Biologic, Inc.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 2 companies; a new generation was cleared every 14.6 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K222831 (Precision Biologic, Inc., 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GJT devices

GJT Plasma, Coagulation Factor Deficient: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GJT

1in 2023

2011: 32018: 12023: 1
2007high 3 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GJT

444in 2011

2011: 444 days median
2007high 444 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GJT

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GJT

1in 2025

2013: 32017: 12018: 62020: 12024: 22025: 1
2007high 6 (2018) · low 0 (2007)2025

MAUDE reports naming product code GJT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
2011344400
20120—00
20130—13
20140—00
20150—00
20160—00
20170—01
20181—06
20190—00
20200—01
20210—00
20220—00
20231—00
20240—02
20250—01
20260—0—

What is it indicated for?

HemosiL Factor VilI deficient plasma is human plasma, depleted of Factor ViII, which is intended for the in vitro diagnostic quantitative determination of Factor ViII activity in citrated plasma, based on the activated partial thromboplastin time (APrT) assay, on the ACL TOP®0 Family analyzers. HemosIL Factor Vill deficient plasma is indicated for use on patients who are suspected of congenital or acquired deficiency based on the activated partial thromboplastin time (APTT) assay results.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110237: Hemosil Factor Viii Deficient Plasma.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110237

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026